𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines

✍ Scribed by Zejia Yang; Patrick J. Faustino; Paul A. Andrews; Rachelle Monastra; Audrey A. Rasmussen; Christopher D. Ellison; Kevin J. Cullen

Publisher
Springer
Year
2000
Tongue
English
Weight
181 KB
Volume
46
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired cisplatin resistance in the hea
Acquired cisplatin resistance in the head–neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1
✍ Eva M. Gosepath; Niels Eckstein; Alexandra Hamacher; Kati Servan; Georg von Jonq 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 301 KB 👁 1 views

## Abstract Head and neck cancers are treated by a combination of surgery, radiotherapy and/or chemotherapy. The clinical success of cisplatin‐based chemotherapy, mostly in combination with 5‐FU or a taxane, is however limited by multifactorial intrinsic or acquired resistance. So far, known genes

Cell cycle changes associated with forma
Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity
✍ Alexandra Vaisman; Maria Varchenko; Isil Said; Stephen G. Chaney 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 1 views

The possible correlation between alterations in cytokinetic response to cisplatin (CP) treatment and drug resistance in human ovarian carcinoma cell lines was examined. Using dual parameter flow cytometry, we performed detailed time-course and dose-response analysis of cell cycle modifications in th

Prediction of treatment outcome by cispl
Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)
✍ Frank J.P. Hoebers; Dick Pluim; Marcel Verheij; Alfons J.M. Balm; Harry Bartelin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 188 KB 👁 1 views

## Abstract The purpose of our study was to test the predictive value of cisplatin‐DNA adduct levels in head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin‐radiation. Patients with advanced‐stage HNSCC were treated within a randomized trial, investigating the optimal route

Protection of platinum–DNA adduct format
Protection of platinum–DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells
✍ Verena Materna; Bernd Liedert; Jürgen Thomale; Hermann Lage 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 411 KB

## Abstract Resistance to platinum‐containing antineoplastic drugs is the major limitation in their clinical use. To elucidate the role of the ABC transporter MRP2 in platinum drug resistance, its expression was analyzed in human cisplatin‐resistant cell lines: the ovarian carcinoma line A2780RCIS,